Professor Ebeling was made an Officer (AO) in the General Division of
the Order of Australia for distinguished service to medicine in the field of
bone health, through academic contributions and research initiatives in a range
of administrative, executive and professional roles.
"The AO is definitely a huge honour and I was pretty astonished to
receive it as it was a total surprise," said Professor Ebeling.
"I have won a number of awards in the past, but being made an AO
surpasses them all as it is such a privilege for me to be considered among the
current and past recipients of this honour."
Professor Ebeling's significant contributions to the field of bone
health are evidenced by his many leadership positions including inaugural
Director of the Australian Institute of
Musculoskeletal Science (AIMSS), Medical Director of Osteoporosis Australia, Board Member,
International Osteoporosis
Foundation, Past-President, Endocrine Society of Australia
and Australian and New Zealand Bone and Mineral Society, and Past-Councillor,
American Society of Bone and Mineral Research.
He also currently serves on the Editorial Board of Osteoporosis
International and is Editor of Clinical Endocrinology (Oxf) and Editor-in-Chief
of Bone Reports and has more than 230 peer-reviewed publications.
Professor Ebeling's research interests include musculoskeletal health
and diseases; public health aspects of vitamin D; post-transplantation
osteoporosis; osteoporosis in men; and biochemical bone turnover markers.
During his doctoral studies with esteemed medical scientist Professor
Jack Martin, Professor Ebeling's team discovered a new hormone, PTHrP, involved
in cancer and normal calcium metabolism. He conducted further clinical research
in osteoporosis as a post-doctoral fellow at the Mayo Clinic and as a visiting
research fellow at the Botnar Centre, Oxford University Institute of
Musculoskeletal Sciences.
Another career highlight of Professor Ebeling's was redefining the
role of an intervention for back pain due to vertebral fractures
(vertebroplasty), a collaborative project with a Monash University research
team.
"Many years ago I was also one of the first researchers to identify
severe bone loss after bone marrow transplantation," added Professor Ebeling.
"Last year I revisited the area and we identified the cytokines responsible as
well as a new treatment to reverse the bone loss."
Professor Ebeling would like to share his AO with colleagues from
scientific and non-government organisations, academia and medicine, with whom he
has had the privilege of working over the years, as well as with his family.
"I have had the fortunate privilege of working with talented teams of
researchers throughout my career so this recognition belongs to them too," said
Professor Ebeling.
"The AO provides a public profile and platform for promoting the
importance of medical research and higher education in Australia."
Other SCS researchers recognised in the Australia Day Honours list were:
Professor John Funder was awarded a Companion of the Order of Australia (AC) for eminent service to medicine, particularly to cardiovascular endocrinology, as a renowned researcher, author and educator, to the development of academic health science centres, and to mental illness, obesity, and Indigenous eye-health programs.
Professor Peter Fuller was awarded a Member (AM) in the General Division of the Order of Australia (AM) for his for significant service to medicine as an endocrinologist, through contributions to medical research and professional organisations.
Adjunct Professor Paul Martin was awarded a Medal of the Order of Australia for services to medicine in the field of psychology.
Read more about Australia Day Honours.
No comments:
Post a Comment